Macrolide Pharmaceuticals' Series B Round

Macrolide Pharmaceuticals raised a round of funding on April 02, 2018.

Macrolide Pharmaceuticals focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens. Using n…

Articles about Macrolide Pharmaceuticals' Series B Round: